Interleaved transcranial magnetic stimulation/functional MRI confirms that lamotrigine inhibits cortical excitability in healthy young men

Neuropsychopharmacology

Volumn 29, Issue 7, 2004, Pages 1395-1407

  Li, Xingbao ^a   Tenebäek, Charlotte C ^a   Nahas, Ziad ^a   Kozel, F Andrew ^a   Large, Charles ^b   Cohn, Jeffrey ^c   Bohning, Daryl E ^a   George, Mark S ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b GSK   (Italy)

^c GLAXOSMITHKLINE   (United States)

Author keywords

Healthy young men; Lamotrigine; Motor cortex; Neuroimaging; Prefrontal cortex; Transcranial magnetic stimulation

Indexed keywords

LAMOTRIGINE; PLACEBO;

ADULT; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; EXCITABILITY; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; LIMBIC SYSTEM; MALE; MOTOR CORTEX; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; OXYGEN BLOOD LEVEL; PREFRONTAL CORTEX; PRIORITY JOURNAL; SINGLE DRUG DOSE; TRANSCRANIAL MAGNETIC STIMULATION;

ADOLESCENT; ADULT; BRAIN MAPPING; CALCIUM CHANNEL BLOCKERS; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTRIC STIMULATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEURAL INHIBITION; OXYGEN; TRANSCRANIAL MAGNETIC STIMULATION; TRIAZINES;

EID: 2942668428     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300452     Document Type: Article

References (65)

1. Alexander GE, DeLong MR, Strick PL (1986). Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9: 357-381.
2. Annett M (1970). A classification of hand preference by association analysis. Br J Psychol 61: 303-321.
3. Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F (2000). Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 47: 305-313.
4. Baudewig J, Siebner HR, Bestmann S, Tergau F, Tings T, Paulus W et al (2001). Functional MRI of cortical activations induced by transcranial magnetic stimulation (TMS). Neuroreport 12: 3543-3548.
5. Baxter Jr LR, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE et al (1989). Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 46: 243-250.
6. Bench CJ, Frackowiak RS, Dolan RJ (1995). Changes in regional cerebral blood flow on recovery from depression. Psychol Med 25: 247-261.
7. Bestmann S, Baudewig J, Frahm J (2003). On the synchronization of transcranial magnetic stimulation and functional echo-planar imaging. J Magn Reson Imaging 17: 309-316.
8. Bohning DE, Denslow S, Bohning PA, Walker JA, George MS (2003). A TMS coil positioning/holding system for MR image-guided TMS interleaved with fMRI. Clin Neurophysiol 114: 2210-2219.
9. Bohning DE, He L, George MS, Epstein CM (2001). Deconvolution of transcranial magnetic stimulation (TMS) maps. J Neural Transm 108: 35-52.
10. Bohning DE, Shastri A, McConnell KA, Nahas Z, Lorberbaum JP, Roberts DR et al (1999). A combined TMS/fMRI study of intensity-dependent TMS over motor cortex. Biol Psychiatry 45: 385-394.
11. Bohning DE, Shastri A, McGavin L, McConnell KA, Nahas Z, Lorberbaum JP et al (2000). Motor cortex brain activity induced by 1-Hz transcranial magnetic stimulation is similar in location and level to that for volitional movement. Invest Radiol 35: 676-683.
12. Boroojerdi B, Battaglia F, Muellbacher W, Cohen LG (2001). Mechanisms influencing stimulus-response properties of the human corticospinal system. Clin Neurophysiol 112: 931-937.
13. Boroojerdi B, Foltys H, Krings T, Spetzger U, Thron A, Topper R (1999). Localization of the motor hand area using transcranial magnetic stimulation and functional magnetic resonance imaging. Clin Neurophysiol 110: 699-704.
14. Buchsbaum MS, Wu J, Siegel BV, Hackett E, Trenary M, Abel L et al (1997). Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry 41: 15-22.
15. Calabrese JR (1999). Lamotrigine and the treatment of bipolar disorder. Introduction. Eur Neuropsychopharmacol 9(Suppl 4 AD): S107-S108.
16. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD (1999). A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 60: 79-88.
17. Calabrese JR, Gajwani P (2000). Lamotrigi ne and clozapine for bipolar disorder. Am J Psychiatry 157: 1523.
18. Catterall WA (1999). Molecular properties of brain sodium channels: an important target for anticonvulsant drugs. Adv Neurol 79: 441-456.
19. Cunningham MO, Jones RS (2000). The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vitro. Neuropharmacology 39: 2139-2146.
20. Dassonville P, Lewis SM, Zhu XH, Ugurbil K, Kim SG, Ashe J (1998). Effects of movement predictability on cortical motor activation. Neurosci Res 32: 65-74.
21. Drevets WC (2000). Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res 126: 413-431.
22. First SR MB, Gibbon M, Williams JBW (1995). Structured Clinical Interview for DSM-IV I Disorder. American Psychiatric Association: Washington, DC.
23. Frodl T, Meisenzahl EM, Zetzsche T, Born C, Groll C, Jager M et al (2002). Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry 159: 1112-1118.
24. Frye MA, Ketter TA, Kimbrell TA, Dunn RT, Speer AM, Osuch EA et al (2000). A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 20: 607-614.
25. George MS, Lisanby SH, Sackeim HA (1999). Transcranial magnetic stimulation: applications in neuropsychiatry. Arch Gen Psychiatry 56: 300-311.
26. George MS, Wassermann EM, Williams WA, Callahan A, Ketter TA, Basser P et al (1995). Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport 6: 1853-1856.
27. Groenewegen HJ, Wright CI, Uylings HB (1997). The anatomical relationships of the prefrontal cortex with limbic structures and the basal ganglia. J Psychopharmacol 11: 99-106.
28. Heckers S, Stone D, Walsh J, Shick J, Koul P, Benes FM (2002). Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch Gen Psychiatry 59: 521-529.
29. Hlustik P, Solodkin A, Gullapalli RP, Noll DC, Small SL (2002). Functional lateralization of the human premotor cortex during sequential movements. Brain Cogn 49: 54-62.
30. Juckel G, Mendlin A, Jacobs BL (1999). Electrical stimulation of rat medial prefrontal cortex enhances forebrain serotonin output: implications for electroconvulsive therapy and transcranial magnetic stimulation in depression. Neuropsychopharmacology 21: 391-398.
31. Ketter TA, Calabrese JR (2002). Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature. J Clin Psychiatry 63: 146-151.
32. Ketter TA, Manji HK, Post RM (2003). Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders. J Clin Psychopharmacol 23: 484-495.
33. Kida I, Hyder F, Behar KL (2001). Inhibition of voltage-dependent sodium channels suppresses the functional magnetic resonance imaging response to forepaw somatosensory activation in the rodent. J Cereb Blood Flow Metab 21: 585-591.
34. Kimbrell TA, Dunn RT, George MS, Danielson AL, Willis MW, Repella JD et al (2002). Left prefrontal-repetitive transcranial magnetic stimulation (rTMS) and regional cerebral glucose metabolism in normal volunteers. Psychiatry Res 115: 101-113.
35. Kimbrell TA, Little JT, Dunn RT, Frye MA, Greenberg BD, Wassermann EM et al (1999). Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry 46: 1603-1613.
36. Levkovitz Y, Grisaru N, Segal M (2001). Transcranial magnetic stimulation and antidepressive drugs share similar cellular effects in rat hippocampus. Neuropsychopharmacology 24: 608-616.
37. Levkovitz Y, Segal M (2001). Aging affects transcranial magnetic modulation of hippocampal evoked potentials. Neurobiol Aging 22: 255-263.
38. MacFall JR, Payne ME, Provenzale JE, Krishnan KR (2001). Medial orbital frontal lesions in late-onset depression. Biol Psychiatry 49: 803-806.
39. Manganotti P, Bongiovanni LG, Zanette G, Turazzini M, Fiaschi A (1999). Cortical excitability in patients after loading doses of lamotrigine: a study with magnetic brain stimulation. Epilepsia 40: 316-321.
40. Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA et al (1999). Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 156: 675-682.
41. Messenheimer JA (1995). Lamotrigine. Epilepsia 36(Suppl 2): S87-S94.
42. Mills KR, Kimiskidis V (1996). Motor cortex excitability during ballistic forearm and finger movements. Muscle Nerve 19: 468-473.
43. Muzina DJ, El-Sayegh S, Calabrese JR (2002). Antiepileptic drugs in psychiatry - focus on randomized controlled trial. Epilepsy Res 50: 195-202.
44. Nahas Z, Lomarev M, Roberts DR, Shastri A, Lorberbaum JP, Teneback C et al (2001). Unilateral left prefrontal transcranial magnetic stimulation (TMS) produces intensity-dependent bilateral effects as measured by interleaved BOLD fMRI. Biol Psychiatry 50: 712-720.
45. Paus T, Jech R, Thompson CJ, Comeau R, Peters T, Evans AC (1997). Transcranial magnetic stimulation during positron emission tomography: a new method for studying connectivity of the human cerebral cortex. J Neurosci 17: 3178-3184.
46. Paus T, Wolforth M (1998). Transcranial magnetic stimulation during PET: reaching and verifying the target site. Hum Brain Mapp 6: 399-402.
47. Rusch BD, Abercrombie HC, Oakes TR, Schaefer SM, Davidson RJ (2001). Hippocampal morphometry in depressed patients and control subjects: relations to anxiety symptoms. Biol Psychiatry 50: 960-964.
48. Saxena S, Brody AL, Ho ML, Alborzian S, Maidment KM, Zohrabi N et al (2002). Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression. Arch Gen Psychiatry 59: 250-261.
49. Shastri A, George MS, Bohning DE (1999). Performance of a system for interleaving transcranial magnetic stimulation with steady-state magnetic resonance imaging. Electroencephalogr Clin Neurophysiol Suppl 51: 55-64.
50. Sheline YI, Gado MH, Price JL (1998). Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport 9: 2023-2028.
51. Smith MJ, Adams LF, Schmidt PJ, Rubinow DR, Wassermann EM (2002). Effects of ovarian hormones on human cortical excitability. Ann Neurol 51: 599-603.
52. Solodkin A, Hlustik P, Noll DC, Small SL (2001). Lateralization of motor circuits and handedness during finger movements. Eur J Neurol 8: 425-434.
53. Southam E, Kirkby D, Higgins GA, Hagan RM (1998). Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats. Eur J Pharmacol 358: 19-24.
54. Speer AM, Kimbrell TA, Wassermann EM, Repella D, Willis MW, Herscovitch P et al (2000). Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry 48: 1133-1141.
55. Strafella AP, Paus T, Barrett J, Dagher A (2001). Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci 21: RC157.
56. Tergau F, Wischer S, Somal HS, Nitsche MA, Joe Mercer A, Paulus W et al (2003). Relationship between lamotrigine oral dose, serum level and its inhibitory effect on CNS: insights from transcranial magnetic stimulation. Epilepsy Res 56: 67-77.
57. i and L-type calcium channel activity in aged hippocampal neurons: relationship to impaired synaptic plasticity. J Neurosci 21: 9744-9756.
58. Villetti G, Bregola G, Bassani F, Bergamaschi M, Rondelli I, Pietra C et al (2001). Preclinical evaluation of CHF3381 as a novel antiepileptic agent. Neuropharmacology 40: 866-878.
59. Waldmeier PC, Martin P, Stocklin K, Portet C, Schmutz M (1996). Effect of carbamazepine, oxcarbazepine and lamotrigine on the increase in extracellular glutamate elicited by veratridine in rat cortex and striatum. Naunyn Schmiedebergs Arch Pharmacol 354: 164-172.
60. Xie X, Hagan RM (1998). Cellular and molecular actions of lamotrigine: possible mechanisms of efficacy in bipolar disorder. Neuropsychobiology 38: 119-130.
61. + channels in rat hippocampal neurones. Pflugers Arch 430: 437-446.
62. Ziemann U, Hallett M, Cohen LG (1998a). Mechanisms of deafferentation-induced plasticity in human motor cortex. J Neurosci 18: 7000-7007.
63. Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W (1996). Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 40: 367-378.
64. Ziemann U, Steinhoff BJ, Tergau F, Paulus W (1998b). Transcranial magnetic stimulation: its current role in epilepsy research. Epilepsy Res 30: 11-30.
65. Ziemann U, Tam A, Butefisch C, Cohen LG (2002). Dual modulating effects of amphetamine on neuronal excitability and stimulation-induced plasticity in human motor cortex. Clin Neurophysiol 113: 1308-1315.